Completed NA INTERVENTIONAL 3-arm NCT00566969

Cocaine Withdrawal and Pharmacotherapy Response (Carvedilol)

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cocaine Dependence Opiate Dependence

Interventions Carvedilol 25 mg Carvedilol 50 mg sugar pill

Updated 8 times since 2017 Last updated: Mar 31, 2020 Started: Sep 30, 2007 Primary completion: Dec 31, 2012 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00566969, this NA trial focuses on Cocaine Dependence and Opiate Dependence and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 8 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

May 2020 — Jan 2021 [monthly]

Completed NA
Jun 2018 — May 2020 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• West Haven, United States